Io Therapeutics Announces Studies On IRX4204 For Breast Cancer
11 Mar 2026 //
GLOBENEWSWIRE
Io Therapeutics` IRX4204 Boosts CAR-T Efficacy in Breast Cancer
11 Dec 2025 //
GLOBENEWSWIRE
Io Therapeutics Unveils BCMA CAR-T, IRX4204 Synergy at ASH
06 Dec 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support